| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.097 | 0.001 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.81 | 0.001 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.001 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.002 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |